DES and adenocarcinoma: In addition, Murugan et al., (2009) evaluated 38 cases of benign mesothelial cells and 39 cases of metastatic adenocarcinoma, and concluded that a combination of positive for EMA and negative for calretinin or desmin had 100% sensitivity and specificity for adenocarcinoma.